GEN Exclusives

More »

GEN Poll

More »
Jul 18, 2013

Clinical Trial Participation

Clinical trials are absolutely necessary in order to make sure a drug works as intended. However, such testing does involve risk, as recently illustrated by Celgene’s decision to stop administering Revlimid® (lenalidomide) in its Phase III ORIGIN® trial because of patient deaths. Suppose you fit a clinical trial’s patient requirements: Would you take the risk?

If you were in a position to do so, would you participate in a clinical trial?

Maybe, if no other treatments worked

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »